Amyloid-beta (1-40) and the risk of death from cardiovascular causes in patients with coronary heart disease.
暂无分享,去创建一个
Christoph Laske | Stefanie Dimmeler | Kimon Stamatelopoulos | Adnan Kastrati | Panagiotis Alexopoulos | A. Kastrati | L. Rallidis | A. Zeiher | S. Dimmeler | M. Alevizaki | C. Laske | C. Varounis | P. Alexopoulos | E. Kastritis | D. Sibbing | D. Stakos | K. Stamatelopoulos | S. Braun | K. Stellos | A. Gatsiou | T. Keller | Aikaterini Gatsiou | Konstantinos Stellos | Maria Alevizaki | Dirk Sibbing | Till Keller | Andreas M Zeiher | Efstathios Kastritis | Siegmund Braun | G. Georgiopoulos | Dimitrios Stakos | A. Tselepis | Christos Varounis | Loukianos S Rallidis | Georgios Georgiopoulos | Kateryna Sopova | Christos Kotakos | Constantinos C Tellis | Alexandros D Tselepis | C. Tellis | K. Sopova | C. Kotakos
[1] L. Kuller,et al. Arterial stiffness and β-amyloid progression in nondemented elderly adults. , 2014, JAMA neurology.
[2] D. Dash,et al. Amyloid β peptide stimulates platelet activation through RhoA‐dependent modulation of actomyosin organization , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[3] D. Allsop,et al. β-Amyloid Fibrils in Alzheimer Disease Are Not Inert When Bound to Copper Ions but Can Degrade Hydrogen Peroxide and Generate Reactive Oxygen Species* , 2014, The Journal of Biological Chemistry.
[4] J. Fleg,et al. Secondary prevention of atherosclerotic cardiovascular disease in older adults: a scientific statement from the American Heart Association. , 2013, Circulation.
[5] J. Lekakis,et al. Lipoprotein-associated phospholipase A(2) bound on high-density lipoprotein is associated with lower risk for cardiac death in stable coronary artery disease patients: a 3-year follow-up. , 2012, Journal of the American College of Cardiology.
[6] Deborah Blacker,et al. Plasma amyloid-β as a predictor of dementia and cognitive decline: a systematic review and meta-analysis. , 2012, Archives of neurology.
[7] H. Tsao,et al. Amyloid peptide regulates calcium homoeostasis and arrhythmogenesis in pulmonary vein cardiomyocytes , 2012, European journal of clinical investigation.
[8] J. Wiltfang,et al. Stability of amyloid‐β peptides in plasma and serum , 2012, Electrophoresis.
[9] T. Beach,et al. Chemical characterization of pro-inflammatory amyloid-beta peptides in human atherosclerotic lesions and platelets. , 2011, Biochimica et biophysica acta.
[10] A. Kastrati,et al. High-sensitivity troponin T level and angiographic severity of coronary artery disease. , 2011, The American journal of cardiology.
[11] F. Grodstein,et al. Plasma amyloid-beta as a predictor of dementia and cognitive decline: A systematic review and meta-analysis , 2011, Alzheimer's & Dementia.
[12] P. Guns,et al. Attenuated atherogenesis in apolipoprotein E-deficient mice lacking amyloid precursor protein. , 2011, Atherosclerosis.
[13] S. Strickland,et al. Alzheimer's disease peptide β-amyloid interacts with fibrinogen and induces its oligomerization , 2010, Proceedings of the National Academy of Sciences.
[14] A. Maggi,et al. Increased atherosclerosis and vascular inflammation in APP transgenic mice with apolipoprotein E deficiency. , 2010, Atherosclerosis.
[15] C. Vlachopoulos,et al. Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness , 2011 .
[16] M. Mogi,et al. Cognitive Deficit in Amyloid-&bgr;–Injected Mice Was Improved by Pretreatment With a Low Dose of Telmisartan Partly Because of Peroxisome Proliferator-Activated Receptor-&ggr; Activation , 2009, Hypertension.
[17] G. Kitas,et al. Atherosclerosis in Rheumatoid Arthritis Versus Diabetes: A Comparative Study , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[18] R. Martins,et al. Clearance mechanisms of Alzheimer's amyloid-β peptide: implications for therapeutic design and diagnostic tests , 2009, Molecular Psychiatry.
[19] L. Lue,et al. Expression of inflammatory genes induced by beta-amyloid peptides in human brain endothelial cells and in Alzheimer's brain is mediated by the JNK-AP1 signaling pathway , 2009, Neurobiology of Disease.
[20] D. Teplow,et al. Identification of antihypertensive drugs which inhibit amyloid-beta protein oligomerization. , 2009, Journal of Alzheimer's disease : JAD.
[21] Wei Zhao,et al. Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease. , 2007, The Journal of clinical investigation.
[22] Tony Wyss-Coray,et al. Inflammation in Alzheimer disease: driving force, bystander or beneficial response? , 2006, Nature Medicine.
[23] M. Fornerod,et al. Characterization of the Drosophila melanogaster genome at the nuclear lamina , 2006, Nature Genetics.
[24] S. Melov,et al. Alzheimer disease β-amyloid activity mimics cholesterol oxidase , 2005 .
[25] S. Melov,et al. Alzheimer disease beta-amyloid activity mimics cholesterol oxidase. , 2005, The Journal of clinical investigation.
[26] Eric J Topol,et al. Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins , 2004, The Lancet.
[27] K. Moore,et al. Fibrillar Amyloid Protein Present in Atheroma Activates CD36 Signal Transduction* , 2004, Journal of Biological Chemistry.
[28] Ann Marie Schmidt,et al. RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain , 2003, Nature Medicine.
[29] Y. Suh,et al. Effects of the β-Amyloid and Carboxyl-terminal Fragment of Alzheimer's Amyloid Precursor Protein on the Production of the Tumor Necrosis Factor-α and Matrix Metalloproteinase-9 by Human Monocytic THP-1* , 2001, The Journal of Biological Chemistry.
[30] C. Bergmann,et al. Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[31] M. Hennerici,et al. Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[32] J. Treanor,et al. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. , 1999, Science.
[33] M. Mullan,et al. β-Amyloid-mediated vasoactivity and vascular endothelial damage , 1996, Nature.
[34] M. Mullan,et al. beta-Amyloid-mediated vasoactivity and vascular endothelial damage. , 1996, Nature.